VAXCYTE INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$62.03
-0.93%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
+10.7%
3 months
+15.9%
6 months
+9.0%
1 year
+38.6%
Year to date
+34.4%
52-week range
$40.32 – $73.82
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$9.23B
P/E
-8.7
P/B
3.3
P/S
—
Revenue
$0
Net income
-$1.06B
Diluted EPS
-7.63
Gross margin
—
Net margin
—
Return on equity
-37.60%
Total debt
$115.45M
Cash
$183.19M
Free cash flow
-$921.07M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $0 | -$284.3M | — | — | -$237.05M |
| Mar 31, 2026 | $0 | -$320.62M | — | — | -$295.42M |
| Dec 31, 2025 | $0 | -$246.51M | — | — | -$233.25M |
| Sep 30, 2025 | $0 | -$212.83M | — | — | -$155.35M |
| Jun 30, 2025 | $0 | -$166.57M | — | — | -$130.92M |
| Mar 31, 2025 | $0 | -$140.72M | — | — | -$193.03M |
| Dec 31, 2024 | $0 | -$137.08M | — | — | -$141.43M |
| Sep 30, 2024 | $0 | -$103.12M | — | — | -$98.79M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent PCVX news
All market newsNo ticker-linked stories are in the current archive.